Buy Like Buffett
Watchlist

Flagship explainer

How PROFOUND MEDICAL CORP. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$16.1M · 100%Cost of revenue$4.7M · 29%Gross profit$11.4M · 71%Operating income−$41.3M · −256%Income before tax−$42.3M · −263%Income tax$252000 · 2%Net income−$42.6M · −264%As of 2025-12-31 · 2 SEC filing sourcesBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$16.1M100%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
Cost of revenue$4.7M29%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
$11.4M71%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
−$41.3M−256%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
Income before tax−$42.3M−263%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
Income tax$2520002%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
−$42.6M−264%
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001104659-26-024153 · filed Mar 5, 2026
· event Dec 31, 2025 · retrieved Oct 20, 2026 · annual-row source set
Embed this chart

View the full PROFOUND MEDICAL CORP. analysis at Buy Like Buffett